Inductive Bio, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Inductive Bio, Inc. - overview
Established
2021
Location
New York, NY, US
Primary Industry
Biotechnology
About
Based in New York, US, and founded in 2021 by CEO Josh Haimson, and CTO Ben Birnbaum, Inductive Bio, Inc. , a. k. a.
Inductive operates as a provider of molecule compound absorption, distribution, metabolism, excretion, and toxicity or ADMET optimization solutions using machine learning. The company provides a machine learning platform that maps the drivers of small molecule absorption, distribution, metabolism, excretion, and toxicity (ADMET) to optimize initial compounds into leads. The platform also allows scientists to develop candidates faster with better ADMENT properties balance that helps in developing new therapeutics. In May 2025, Inductive Bio, Inc.
raised USD 25 million in series A funding led by Obvious Ventures, with participation from Andreessen Horowitz, Amino Collective, Character, Lux Capital, and Section 32. Individual investors also participated in the round. The company plans to utilize the May 2025 funding to model research and development expansion, consortium growth and technology deployment.
Current Investors
Bessemer Venture Partners, Lux Capital, Andreessen Horowitz
Primary Industry
Biotechnology
Sub Industries
Bioinformatics
Website
www.inductive.bio/
Verticals
Artificial Intelligence
Company Stage
Series A
Total Amount Raised
Subscriber access only
Inductive Bio, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.